SCHEMBL9738865

SCHEMBL9738865

CCOC(=O)C(C(C)=O)c1ccccc1Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 1/20 0.55
HPGD P15428 1/20 0.46
ALOX15 P16050 1/20 0.46
MMP8 P22894 1/20 0.45
PIN1 Q13526 1/20 0.41
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
RAB9A P51151 1/20 0.41
ALDH1A1 P00352 3/20 0.41
ELANE P08246 1/20 0.41
TSHR P16473 3/20 0.41
NPC1 O15118 1/20 0.41
NLRP3 Q96P20 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
EPHX2 P34913 1/20 0.38
LMNA P02545 1/20 0.38
PDE4B Q07343 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5861445 0.92 CASP1 (0.59) CASP1MMP8PIN1KMT2AMEN1
SCHEMBL1717197 0.84 CASP1 (0.43) CASP1HPGDALOX15MMP8PIN1
SCHEMBL9610107 0.81 CYP1A2 (0.40) CASP1HPGDALOX15MMP8KMT2A
SCHEMBL8027004 0.81 CYP3A4 (0.47) HPGDALOX15KMT2AMEN1ALDH1A1
SCHEMBL13228090 0.81 CASP1 (0.49) CASP1MMP8PIN1KMT2AMEN1
SCHEMBL8105959 0.81 POLB (0.47) MMP8PIN1KMT2AMEN1TSHR
SCHEMBL4632797 0.80 CASP1 (0.70) CASP1MMP8PIN1KMT2AMEN1
SCHEMBL4632799 0.80 CASP1 (0.70) CASP1MMP8PIN1KMT2AMEN1
SCHEMBL5322140 0.80 CASP1 (0.57) CASP1HPGDMMP8PIN1KMT2A
SCHEMBL10708969 0.80 CASP1 (0.57) CASP1HPGDPIN1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5100897-A Hypotensive agents, congestive heart failure, ocular hypertension MERCK & CO., INC. (US) 1992-03-31 US disclosed
EP-0419048-A2 Substituted pyrimidinones as angiotensin II antagonists MERCK & CO. INC. (US) 1991-03-27 EP disclosed